GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $94,138,000 | +19718.5% | 815,681 | +28824.9% | 1.14% | +8042.9% |
| Q1 2019 | $475,000 | +72.7% | 2,820 | 0.0% | 0.01% | +27.3% |
| Q4 2018 | $275,000 | -99.2% | 2,820 | -99.2% | 0.01% | -99.4% |
| Q3 2017 | $34,358,000 | -23.0% | 338,536 | -23.9% | 1.70% | -37.6% |
| Q2 2017 | $44,605,000 | +10.9% | 444,936 | +33.8% | 2.72% | +4.0% |
| Q1 2017 | $40,218,000 | -1.7% | 332,544 | -9.2% | 2.61% | -26.0% |
| Q4 2016 | $40,908,000 | -43.5% | 366,068 | -32.9% | 3.53% | -38.8% |
| Q3 2016 | $72,460,000 | +1120.3% | 545,922 | +563.3% | 5.76% | +847.9% |
| Q1 2016 | $5,938,000 | -66.9% | 82,300 | -43.6% | 0.61% | -58.6% |
| Q2 2015 | $17,938,000 | +65.3% | 146,027 | +22.6% | 1.47% | +50.8% |
| Q1 2015 | $10,855,000 | -43.5% | 119,114 | -63.2% | 0.98% | -57.5% |
| Q1 2014 | $19,211,000 | +28.5% | 323,583 | -10.1% | 2.29% | +24.3% |
| Q4 2013 | $14,953,000 | +422.6% | 359,977 | +118.1% | 1.84% | +328.1% |
| Q3 2013 | $2,861,000 | – | 165,020 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |